Trials / Completed
CompletedNCT00448955
Open-Label Study of ARD-0403 in Testosterone Deficient Men
A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Ardana Bioscience Ltd · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient wellbeing. The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARD-0403 | ARD-0403 |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2007-03-19
- Last updated
- 2008-04-18
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00448955. Inclusion in this directory is not an endorsement.